Side Effects During the Double-blind Part of the Study
30 mg Apremilast
Twice Daily Placebo
(298 participants) (296 participants)
How many participants 0 participants 1 participant
had serious side effects? (0%) (less than 1%)
How many participants
110 participants 35 participants
had non-serious side
(37%) (12%)
effects?
How many participants 0 participants 0 participants
died from side effects? (0%) (0%)
How many participants
stopped taking the study 11 participants 5 participants
medicine because of side (4%) (2%)
effects?
Side Effects During the Open-label Part of the Study
30 mg Apremilast
Twice Daily
(544 participants)
How many participants 0 participants
had serious side effects? (0%)
How many participants
186 participants
had non-serious side
(34%)
effects?
How many participants 0 participants
died from side effects? (0%)
How many participants
stopped taking the study 17 participants
medicine because of side (3%)
effects?
If a participant had to stay in the hospital or died because of a side effect, the doctor
reported that the side effect was serious. No participant died due to a side effect.
The table below shows the serious side effects.
7